NIEL, Belgium and MORRISVILLE, North Carolina, December 6, 2010 /PRNewswire/ -- unithink NV announced that it has named John Cline CEO of the company. Cline comes to unithink after successful stints at National Clinical Research and etrials, where he was a founder and CEO.
While at etrials, Cline led the company through angel and venture funding rounds that led to the successful IPO in February, 2006. A finalist for the Ernst & Young Entrepreneur of the Year award in 2007, Cline was responsible for leading the company operations for over six years and garnering a spot on the Inc. 500 list of fastest growing privately held companies in the U.S. etrials provides software used by drug companies and contract research organizations in the running of clinical trials, and was acquired by Merge Healthcare in 2009.
"John brings a wealth of experience in the CRO market that we need to help position unithink as a leader in the market," said Anthony DeClerck, Chairman at unithink. "In looking for a CEO, we wanted someone that understood our clients and could grow our presences in the U.S. and international markets. John is the ideal person to do just that."
Cline has over 25 years of experience in the pharmaceutical industry, including senior sales and marketing roles at Organon Inc., Caremark, a division of Baxter, and MiniDoc AB, a publicly held Swedish corporation. Mr. Cline also served as President, CEO and director of Expidata Inc., which was acquired by etrials in 2000. Cline is a graduate of the University of Georgia with a BS, Journalism.
unithink was founded in 2005 as a small team providing solutions to pharmaceutical and biotech clients on a "customised solutions per study" basis with a clinical approach. Since then, unithink has grown into a multi-national company with corporate headquarters at Waterfront Research Park, Niel, Antwerp, Belgium, and with offices in India, Germany and the USA at Research Triangle Park, North Carolina.
About unithink
unithink's unique approach, developed over the last 5 years, makes eClinical software and techniques affordable and accessible for all enterprises. unithink strives to help the world's most innovative biopharmaceutical and medical device organizations bring muchneeded medical solutions to the market faster. Visit http://www.unithink.com or call +32-3-298-00-57 in Europe; +1-919-328-5800 in the U.S.; or email info@unithink.com.
SOURCE: unithink
CONTACT: John Cline, +1-919-328-5810, john.cline@unithink.com
Comments